Immune-Cell-Derived Exosomes for Cancer Therapy | Molecular Pharmaceutics
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity | Cell Research
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer | Cell Death & Disease
Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma | Genes & Immunity
T follicular helper cells in cancer: Trends in Cancer
Frontiers | Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma - ScienceDirect
Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
What Are Immune Checkpoints?
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Frontiers | Research progress in inducing immunogenic cell death of tumor cells
Current Oncology | Free Full-Text | Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Systemic immunity in cancer | Nature Reviews Cancer
The Contribution of Epigenetics to Cancer Immunotherapy: Trends in Immunology
Frontiers | Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
Frontiers | Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
Biology | Free Full-Text | Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
DNA Methylation and Anticancer Drug Resistance in Gynecological Tumors
Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response | ACS Nano
Frontiers | The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
